Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by steadfaston Jan 07, 2022 12:27pm
324 Views
Post# 34293381

Doug Loe has done it again

Doug Loe has done it again
Jan 18 2021   SVA trades at $2.87 in early trading.  Doug Loe issues a Target of $2.50
                     Momentum is destroyed.  HIs firm participates in Bot Deal @ $1.20
Jan  7, 2022   SVA opens at $2.21.  Doug Loe issues a Target of $2.50
                     Once again momentum is destroyed.
It is almost impossible to believe he can do this 2 years in a row. If he can't raise his
target after a year, he should not write at all.
If I was  Mgt   I would fire him today and ensure he never writes another report on SVA

This is beyond Ridiculous.  Dr T continually advises shareholders we are worth $1B U.S.
today due to Vertex/Semma deal.  That is $3.48 Can not $2.50.  Once the stock reaches $3.10, the bot deal wts get called and it is worth $40M to SVA.  A deal with a Pharma likely
adds another $1B US.
Doug has presented a new Challenge to the IR Guys, they are going to have to work harder
to get the momentum going and get the stock back to $2.21 this afternoon.  We had good
momentum going into Monday.  We cannot allow Doug to destroy the momentum in 2022.
<< Previous
Bullboard Posts
Next >>